Inari Medical Inc. (NARI)
NASDAQ (NGS) NASDAQ (NGS) Primary 
Inari Medical (NARI) Issues Notice Post ClotTriever XL Recall
Inari Medical (NARI) issues urgent updates to ClotTriever XL Catheter instructions following the FDA's recall after reports of serious injuries and deaths.
Inari Medical (NARI) Q2 Earnings Miss, Revenues Increase Y/Y
Inari Medical's (NARI) second-quarter results witness an increase in revenues with dismal bottom-line performance. Gross margins contract while the company continues to incur operating losses.
Inari Medical, Inc. (NARI) Q2 2024 Earnings Call Transcript
Start Time: 16:30 January 1, 0000 2:24 PM ET Inari Medical, Inc. (NASDAQ:NARI ) Q2 2024 Earnings Conference Call July 30, 2024, 16:30 PM ET Company Participants Drew Hykes - President and CEO Mitch Hill - CFO Tom Tu - Chief Medical Officer Kevin Strange - SVP of Finance, Accounting, Strategy and Business Development Marissa Bych - Gilmartin Group LLC Conference Call Participants Kallum Titchmarsh - Morgan Stanley Stephanie Pezzi - Bank of America Marie Thibault - BTIG Bill Plovanic - Canaccord Chris Pasquale - Nephron Research Adam Maeder - Piper Sandler Richard Newitter - Truist Margaret Kaczor - William Blair Operator Good afternoon, everyone, and welcome to the Inari Medical, Inc. Second Quarter 2024 Earnings Conference Call. All participants are in a listen-only mode.
Inari Medical, Inc. (NARI) Reports Q2 Loss, Tops Revenue Estimates
Inari Medical, Inc. (NARI) came out with a quarterly loss of $0.41 per share versus the Zacks Consensus Estimate of a loss of $0.16. This compares to earnings of $0.04 per share a year ago.
Inari Medical, Inc. (NARI) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
Inari Medical (NARI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Inari Medical, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before July 12, 2024 to Discuss Your Rights - NARI
NEW YORK, NY / ACCESSWIRE / July 12, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
Investors in Inari Medical, Inc. Should Contact Levi & Korsinsky Before July 12, 2024 to Discuss Your Rights - NARI
NEW YORK, NY / ACCESSWIRE / July 12, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
Shareholders that lost money on Inari Medical, Inc. (NARI) should contact Levi & Korsinsky about pending Class Action - NARI
NEW YORK, NY / ACCESSWIRE / July 12, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
FINAL NARI DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Inari Medical, Inc. Investors to Join the Class Action Lawsuit!
NEW YORK, NY / ACCESSWIRE / July 12, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Inari Medical, Inc. ("Inari" or "the Company") (NASDAQ:NARI) and certain of its officers. Class Definition: This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Inari securities between March 10, 2021 and February 28, 2024, inclusive (the "Class Period").
Shareholders that Lost Money on Inari Medical, Inc.(NARI) Should Contact Levi & Korsinsky About Pending Class Action - NARI
NEW YORK, NY / ACCESSWIRE / July 12, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
The Schall Law Firm Calls On Shareholders Who Suffered Losses In Inari Medical Inc To Start Conversation As It Begins A Probe
LOS ANGELES, CA / ACCESSWIRE / July 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Inari Medical, Inc. ("Inari" or "the Company") (NASDAQ:NARI) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 24, 2022 and February 28, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before July 12, 2024.
Levi & Korsinsky Reminds Inari Medical, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 12, 2024 - NARI
NEW YORK, NY / ACCESSWIRE / July 12, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
